These findings are highly significant as they suggest that the use of miRNAs as targets for future therapeutic design might be effective in treating the chronic slow cell death phase of retinal degenerative diseases regardless of the initiating mutation.
← all excerpts
Altered miRNA expression in canine retinas during normal development and in models of retinal degeneration.
1
—
—